| Literature DB >> 22410346 |
Chang Sik Son1, Byoung Kuk Jang, Suk Tae Seo, Min Soo Kim, Yoon Nyun Kim.
Abstract
BACKGROUND: The aim of this study is to develop a simple and reliable hybrid decision support model by combining statistical analysis and decision tree algorithms to ensure high accuracy of early diagnosis in patients with suspected acute appendicitis and to identify useful decision rules.Entities:
Mesh:
Year: 2012 PMID: 22410346 PMCID: PMC3314559 DOI: 10.1186/1472-6947-12-17
Source DB: PubMed Journal: BMC Med Inform Decis Mak ISSN: 1472-6947 Impact factor: 2.796
Comparison of patient characteristics (age, gender, chief complaints, and urinalysis) for acute appendicitis and discharged patients (n = 326)
| Characteristics | AA* (n = 152) | Control** | |
|---|---|---|---|
| Age, yrs† | 36.57 ± 21.31 | 43.05 ± 20.86 | 0.003†† |
| Gender | 0.021 | ||
| Male | 77 (50.7%) | 66 (37.9%) | |
| Female | 75 (49.3%) | 108 (62.1%) | |
| Chief complaints | 0.000†† | ||
| abdominal | 76 (50.0%) | 109 (62.6%) | |
| left upper quadrant (LUQ) | 0 (0.0%) | 1 (0.6%) | |
| periumbilical area | 4 (2.6%) | 10 (5.7%) | |
| right lower quadrant (RLQ) | 60 (39.5%) | 16 (9.2%) | |
| left lower quadrant (LLQ) | 0 (0.0%) | 5 (2.9%) | |
| lower abdominal | 5 (3.3%) | 18 (10.3%) | |
| right upper quadrant (RUQ) | 6 (3.9%) | 15 (8.6%) | |
| upper abdominal | 1 (0.7%) | 0 (0.0%) | |
| Urinalysis | |||
| Color | 0.407 | ||
| amber | 10 (6.6%) | 6 (3.4%) | |
| brown | 1 (0.7%) | 1 (0.6%) | |
| straw | 140 (92.1%) | 167 (96.0%) | |
| yellow | 1 (0.7%) | 0 (0.0%) | |
| S.G.† | 1.02 ± 0.01 | 1.02 ± 0.01 | 0.106 |
| pH† | 6.61 ± 0.93 | 6.43 ± 0.92 | 0.086 |
| Albumin | 0.412 | ||
| negative | 127 (83.6%) | 151 (86.8%) | |
| positive | 25 (16.4%) | 23 (13.2%) | |
| Glucose | 0.000†† | ||
| negative | 116 (76.3%) | 170 (97.7%) | |
| positive | 36 (23.7%) | 4 (2.3%) | |
| Ketone | 0.000†† | ||
| negative | 98 (64.5%) | 149 (85.6%) | |
| positive | 54 (35.5%) | 25 (14.4%) | |
| O.B. | 0.578 | ||
| negative | 104 (68.4%) | 114 (65.5%) | |
| positive | 48 (31.6%) | 60 (34.5%) | |
| Urobilinogen, E.U./dL† | 0.52 ± 1.49 | 0.22 ± 0.54 | 0.020 |
| Bilirubin | 0.983 | ||
| negative | 139 (91.4%) | 159 (91.4%) | |
| positive | 13 (8.6%) | 15 (8.6%) | |
| Nitrite | 0.689 | ||
| negative | 150 (98.7%) | 170 (97.7%) | |
| positive | 2 (1.3%) | 4 (2.3%) | |
| WBC1 | 0.345 | ||
| negative | 99 (65.1%) | 122 (70.1%) | |
| positive | 53 (34.9%) | 52 (29.9%) | |
| RBC | 0.972 | ||
| negative | 53 (34.9%) | 61 (35.1%) | |
| positive | 99 (65.1%) | 113 (64.9%) | |
| WBC2 | 0.936 | ||
| negative | 11 (7.2%) | 13 (7.5%) | |
| positive | 141 (92.8%) | 161 (92.5%) | |
| Ep. Cell | 0.303 | ||
| negative | 30 (19.7%) | 26 (14.9%) | |
| positive | 122 (80.3%) | 148 (85.1%) | |
| Cast | 0.284 | ||
| negative | 151 (99.3%) | 174 (100.0%) | |
| positive | 1 (0.7%) | 0 (0.0%) | |
| Other | 0.184 | ||
| negative | 147 (96.7%) | 172 (98.9%) | |
| positive | 5 (3.3%) | 2 (1.1%) | |
| Crystal | 0.383 | ||
| negative | 151 (99.3%) | 171 (98.3%) | |
| positive | 1 (0.7%) | 3 (1.7%) | |
* acute appendicitis; ** discharged patients; † Mean ± SD; †† p < 0.01
Figure 1Scheme of the decision support models.
Comparison of patient characteristics (CBC & Differential Count, Serum Electrolytes, Routine Admission, etc.) for acute appendicitis and discharged patients (n = 326)
| Characteristics | AA* | Control** | |
|---|---|---|---|
| CBC & Differential Count† | |||
| WBC, × 103/μL | 13.47 ± 4.90 | 9.47 ± 3.91 | 0.000†† |
| RBC, × 103/μL | 4.50 ± 0.55 | 4.29 ± 0.59 | 0.001†† |
| HGB, g/dL | 13.51 ± 1.83 | 13.08 ± 1.83 | 0.037 |
| HCT,% | 39.03 ± 4.92 | 37.93 ± 5.23 | 0.027 |
| MCV, fl | 86.96 ± 5.54 | 88.58 ± 5.69 | 0.010 |
| MCH, pg | 30.16 ± 2.24 | 30.62 ± 2.32 | 0.074 |
| MCHC, g/dL | 34.73 ± 1.33 | 34.59 ± 1.34 | 0.343 |
| PLT, × 103/μL | 268.69 ± 81.29 | 262.43 ± 78.51 | 0.480 |
| NEUT,% | 81.48 ± 8.62 | 69.28 ± 14.14 | 0.000†† |
| LYMP,% | 12.51 ± 6.95 | 22.75 ± 12.49 | 0.000†† |
| MONO,% | 4.08 ± 1.91 | 4.67 ± 1.78 | 0.000†† |
| EOS,% | 1.30 ± 0.91 | 2.14 ± 1.70 | 0.000†† |
| BASO,% | 0.37 ± 0.27 | 0.49 ± 0.37 | 0.000†† |
| LUC,% | 1.20 ± 0.73 | 1.73 ± 0.99 | 0.000†† |
| MPV, fl | 7.72 ± 0.68 | 7.76 ± 0.73 | 0.633 |
| Serum Electrolyte† | |||
| Na, mmol/L | 143.11 ± 2.83 | 144.01 ± 3.35 | 0.000†† |
| K, mmol/L | 4.19 ± 0.44 | 4.21 ± 0.42 | 0.705 |
| Cl, mmol/L | 106.12 ± 3.25 | 107.25 ± 3.83 | 0.000†† |
| Routine Admission† | |||
| Calcium (T), mg/dL | 9.11 ± 0.52 | 9.10 ± 0.52 | 0.874 |
| Inorganic Phosphorus, mg/dL | 3.36 ± 0.82 | 3.43 ± 0.80 | 0.490 |
| Glucose, mg/dL | 127.39 ± 36.23 | 116.61 ± 40.64 | 0.001†† |
| BUN, mg/dL | 13.15 ± 7.92 | 13.86 ± 6.44 | 0.376 |
| Creatinine, mg/dL | 0.88 ± 0.25 | 0.94 ± 0.51 | 0.229 |
| Cholesterol (T), mg/dL | 169.19 ± 37.91 | 174.44 ± 38.84 | 0.219 |
| Protein (T), g/dL | 7.21 ± 0.63 | 7.18 ± 0.57 | 0.650 |
| Albumin, g/dL | 4.23 ± 0.37 | 4.20 ± 0.36 | 0.404 |
| Bilirubin (T), mg/dL | 1.24 ± 0.66 | 0.90 ± 0.48 | 0.000†† |
| Bilirubin (D), mg/dL | 0.36 ± 0.16 | 0.26 ± 0.17 | 0.000†† |
| ALP, U/L | 97.61 ± 70.85 | 88.05 ± 52.93 | 0.174 |
| AST, U/L | 25.70 ± 12.84 | 31.01 ± 27.80 | 0.025 |
| ALT, U/L | 22.97 ± 20.90 | 24.70 ± 19.75 | 0.444 |
| APTT†, s | 29.92 ± 4.78 | 29.43 ± 12.01 | 0.007†† |
| PT†, s | 1.03 ± 0.12 | 1.01 ± 0.13 | 0.028 |
| Lipase†, U/L | 24.14 ± 7.70 | 31.70 ± 16.89 | 0.000†† |
| Amylase (T)†, U/L | 46.86 ± 27.77 | 55.04 ± 26.90 | 0.000†† |
* acute appendicitis; ** discharge patients; † Mean ± SD; †† p < 0.01
Multivariate analysis of predictors of acute appendicitis (entry and removal criteria of 0.01 and 0.05, or 0.05 and 0.10)
| Variables | Coefficient (β) | Standard error | OR (95% CI) | ||
|---|---|---|---|---|---|
| Complaints** | 0.000 | ||||
| LUQ | -19.774 | 40192.97 | - | 1.000 | |
| PA† | -0.725 | 0.754 | 0.484 (0.111-2.121) | 0.336 | |
| RLQ | 1.838 | 0.397 | 6.281 (2.883-13.687) | 0.000 | |
| LLQ | -18.848 | 17365.29 | - | 0.999 | |
| Lower abd. | -1.215 | 0.697 | 0.297 (0.076-1.163) | 0.081 | |
| RUQ | -0.047 | 0.784 | 0.954 (0.205-4.433) | 0.952 | |
| Upper abd. | 19.292 | 40192.97 | 2.390E8 (-) | 1.000 | 0.838 |
| Urine glucose (positive) | 2.537 | 0.644 | 12.636 (3.575-44.658) | 0.000 | |
| WBC | 0.116 | 0.043 | 1.123 (1.033-1.221) | 0.007 | |
| NEUT | 0.057 | 0.017 | 1.059 (1.023-1.095) | 0.001 | |
| Bilirubin (T) | 0.795 | 0.268 | 2.213 (1.308-3.746) | 0.003 | |
| Lipase | -0.042 | 0.016 | 0.958 (0.928-0.989) | 0.009 | |
| Intercept | -6.035 | 1.290 | - | 0.000 |
R2 = 0.428; n = 326
* Hosmer-Lemeshow goodness-of-fit (H) statistic
** abdominal pain as reference category
† periumbilical area
Statistical significance of cut-off points determined using the C5.0 decision tree algorithm (for multivariate analysis)
| Variables | OR (95% CI) | |
|---|---|---|
| NEUT ≤ 73.1% or > 73.1% | 11.506 (6.244-21.202) | 0.000 |
| Urine glucose (negative) | 0.041 (0.006-0.310) | 0.002 |
| Urine glucose (positive) | 24.115 (3.227-180.216) | 0.002 |
| Abdominal pain | 2.722 (1.445-5.125) | 0.002 |
| LUQ pain | 0.732 (0.014-37.307) | 0.876 |
| PA or RLQ or Upper abdominal pain | 5.880 (2.727-12.681) | 0.000 |
| LLQ or Lower abdominal or RUQ pain | 4.231 (1.292-13.855) | 0.017 |
| Bilirubin (T) ≤ 1.0 mg/dL or > 1.0 mg/dL | 6.200 (2.604-14.762) | 0.000 |
| Lipase ≤ 46 U/L or > 46 U/L | 37.800 (1.829-781.085) | 0.019 |
* LUQ, left upper quadrant; PA, periumbilical area; RLQ, right lower quadrant; LLQ, left lower quadrant; RUQ, right upper quadrant
Figure 2Decision support model based on Wald logistic regression (entry and removal of 0.01 and 0.05, or 0.05 and 0.10).
Statistical significance of cut-off points determined using the C5.0 decision tree algorithm (for univariate analysis)
| Variables | OR (95% CI) | |
|---|---|---|
| LYMP ≤ 20.2% or > 20.2% | 12.527 (6.335-24.770) | 0.000 |
| Urine glucose (negative) | 0.036 (0.005-0.270) | 0.001 |
| Urine glucose (positive) | 27.645 (3.709-206.043) | 0.001 |
| BASO ≤ 1.1% | 9.333 (1.169-74.489) | 0.035 |
| BASO > 1.1% | 0.107 (0.013-0.8555) | 0.035 |
| Abdominal pain | 4.487 (2.556-7.878) | 0.000 |
| LUQ or LLQ or RUQ pain | 4.594 (0.929-22.712) | 0.062 |
| APA pain | 1.087 (0.237-4.994) | 0.914 |
| RLQ pain | 7.447 (3.274-16.938) | 0.000 |
| Lower abdominal pain | 6.058 (1.273-28.826) | 0.024 |
| Upper abdominal pain | 2.465 (0.099-61.267) | 0.582 |
| WBC ≤ 6.2 × 103/μL or > 6.2 × 103/μL | 25.000 (0.341-1831.738) | 0.142 |
| Bilirubin (T) ≤ 1.0 mg/dL or > 1.0 mg/dL | 6.576 (2.791-15.493) | 0.000 |
| WBC ≤ 14.37 × 103/μL or > 14.37 × 103/μL | 63.000 (0.982-4042.374) | 0.051 |
| Cl ≤ 104 mmol/L | 9.197 (0.499-169.573) | 0.136 |
| Cl > 104 mmol/L | 0.109 (0.006-2.005) | 0.136 |
| Bilirubin (D) ≤ 0.4 mg/dL or > 0.4 mg/dL | 95.000 (1.482-6088.126) | 0.032 |
| Amylase (T) ≤ 58 U/L | 0.033 (0.002-0.584) | 0.020 |
| Amylase (T) > 58 U/L | 29.881 (1.1711-521.765) | 0.020 |
| APTT ≤ 22.6 s or > 22.6 s | 37.800 (1.829-781.085) | 0.019 |
| Urine ketone (negative) | 0.667 (0.113-3.919) | 0.654 |
| Urine ketone (positive) | 1.500 (0.255-8.817) | 0.654 |
| MONO ≤ 2.4% or > 2.4% | 19.667 (1.022-378.446) | 0.048 |
| NEUT ≤ 84% | 0.055 (0.003-1.051) | 0.054 |
| NEUT > 84% | 18.103 (0.951-344.559) | 0.054 |
| MONO ≤ 3.6% or > 3.6% | 29.000 (1.413-595.209) | 0.029 |
| EOS ≤ 2.4% | 0.077 (0.004-1.426) | 0.085 |
| EOS > 2.4% | 13.047 (0.701-242.739) | 0.085 |
| LYMP ≤ 13.8% or > 13.8% | 49.286 (2.214-1097.056) | 0.014 |
| EOS ≤ 1.5% or > 1.5% | 47.667 (1.597-1422.784) | 0.026 |
| Urine ketone (negative or positive) | 1.932 (0.423-8.814) | 0.395 |
| Bilirubin (D) ≤ 0.3 mg/dL or > 0.3 mg/dL | 25.000 (0.750-832.997) | 0.072 |
| Glucose ≤ 124 mg/dL or > 124 mg/dL | 25.706 (1.307-505.514) | 0.033 |
| BASO ≤ 0.4% or > 0.4% | 12.600 (0.446-356.388) | 0.137 |
| Cl ≤ 107 mmol/L or > 107 mmol/L | 18.667 (1.563-222.937) | 0.021 |
| RBC ≤ 4.14 × 103/μL or > 4.14 × 103/μL | 25.000 (0.750-832.997) | 0.072 |
* LUQ, left upper quadrant; LLQ, left lower quadrant; RUQ, right upper quadrant; PA, periumbilical area; RLQ, right lower quadrant
Figure 3Decision support model based on univariate analysis.
Clinical factors selected before the application of C5.0 decision tree algorithm during 10-fold cross validation
| Variables | Fold 1 | Fold 2 | Fold 3 | Fold 4 | Fold 5 | Fold 6 | Fold 7 | Fold 8 | Fold 9 | Fold 10 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M1 | M2 | M3 | M1 | M2 | M3 | M1 | M2 | M3 | M1 | M2 | M3 | M1 | M2 | M3 | M1 | M2 | M3 | M1 | M2 | M3 | M1 | M2 | M3 | M1 | M2 | M3 | M1 | M2 | M3 | |
| Age | O | O | O | O | O | O | ||||||||||||||||||||||||
| Complaints | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | ||
| Urine pH | O | O | ||||||||||||||||||||||||||||
| Urine glucose | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | ||
| Urine ketone | O | O | O | O | O | O | O | O | O | O | ||||||||||||||||||||
| Urine Urobilinogen | O | O | O | |||||||||||||||||||||||||||
| WBC | O | O | O | O | O | O | O | O | O | O | O | O | O | |||||||||||||||||
| RBC | O | O | O | O | O | O | O | O | O | O | ||||||||||||||||||||
| NEUT | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O |
| LYMP | O | O | O | O | O | O | O | O | O | O | ||||||||||||||||||||
| MONO | O | O | O | O | O | |||||||||||||||||||||||||
| EOS | O | O | O | O | O | O | O | O | O | O | O | |||||||||||||||||||
| BASO | O | O | O | O | O | O | O | O | O | O | ||||||||||||||||||||
| LUC | O | O | O | O | O | O | O | O | O | O | ||||||||||||||||||||
| Bilirubin (T) | O | O | O | O | O | O | O | O | O | O | O | |||||||||||||||||||
| Bilirubin (D) | O | O | O | O | O | O | O | O | O | O | O | O | O | |||||||||||||||||
| Lipase | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | ||||||||||
| Amylase (T) | O | O | ||||||||||||||||||||||||||||
M1: univariate analysis (p < 0.01)
M2: multivariate analysis (entry and removal criteria of 0.01 and 0.05)
M3: multivariate analysis (entry and removal criteria of 0.05 and 0.10)
Clinical factors selected after the application of C5.0 decision tree algorithm during 10-fold cross validation
| Variables | Fold 1 | Fold 2 | Fold 3 | Fold 4 | Fold 5 | Fold 6 | Fold 7 | Fold 8 | Fold 9 | Fold 10 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M1 | M2 | M3 | M1 | M2 | M3 | M1 | M2 | M3 | M1 | M2 | M3 | M1 | M2 | M3 | M1 | M2 | M3 | M1 | M2 | M3 | M1 | M2 | M3 | M1 | M2 | M3 | M1 | M2 | M3 | |
| Age | O | O | O | O | ||||||||||||||||||||||||||
| Complaints | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | |||
| Urine pH | O | O | ||||||||||||||||||||||||||||
| Urine glucose | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | |||||
| Urine ketone | O | O | O | O | O | O | ||||||||||||||||||||||||
| WBC | O | O | O | O | O | O | O | O | O | O | O | O | ||||||||||||||||||
| RBC | O | O | O | O | O | O | O | |||||||||||||||||||||||
| NEUT | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | |||||
| LYMP | O | O | O | O | O | O | O | O | O | O | ||||||||||||||||||||
| MONO | O | |||||||||||||||||||||||||||||
| EOS | O | O | O | O | O | O | O | O | ||||||||||||||||||||||
| BASO | O | O | O | O | O | O | O | O | O | O | ||||||||||||||||||||
| LUC | O | O | O | O | O | O | O | O | O | |||||||||||||||||||||
| Bilirubin (T) | O | O | O | O | O | O | O | O | O | O | ||||||||||||||||||||
| Bilirubin (D) | O | O | O | O | O | O | O | O | O | O | O | |||||||||||||||||||
| Lipase | O | O | O | O | O | O | O | O | O | O | O | O | O | O | O | |||||||||||||||
| Amylase (T) | O | O | ||||||||||||||||||||||||||||
M1: C5.0 decision tree algorithm with univariate analysis (p < 0.01)
M2: C5.0 decision tree algorithm with multivariate analysis (entry and removal criteria of 0.01 and 0.05)
M3: C5.0 decision tree algorithm with multivariate analysis (entry and removal criteria of 0.05 and 0.10)
Performance of decision support models based on univariate and multivariate analysis (10-fold cross validation)
| Performance | ACC | SENS | SPEC | PPV | NPV | AUC |
|---|---|---|---|---|---|---|
| 80.2 | 82.4 | 78.3 | 76.8 | 83.5 | 80.3 | |
| 71.6 | 69.3 | 73.7 | 69.7 | 73.3 | 71.5 | |
| 73.5 | 66.0 | 80.0 | 74.3 | 72.9 | 73.0 |
* p < 0.01; standard error: 2.54 (95% CI, 75.6-84.5)
** entry and removal criteria of 0.01 and 0.05; standard error: 2.89 (95% CI, 66.3-76.3)
† entry and removal criteria of 0.05 and 0.10; standard error: 2.86 (95% CI, 67.9-77.7)
Discriminatory capacity of decision support models used for the diagnosis of acute appendicitis expressed as areas under ROC curves (95% CI)
| Pairwise | Based on univariate analysis* | Based on multivariate analysis** | |
|---|---|---|---|
| Based on univariate analysis* | - | ||
| Based on multivariate analysis** | - | ||
| Based on multivariate analysis† | - |
* p < 0.01
** entry and removal criteria of 0.01 and 0.05
† entry and removal criteria of 0.05 and 0.10
Figure 4Comparison of ROC curves for the decision support models.